ArticleFrontiers in immunology2025

Construction of anti-HER2 affibody-directed CAR-NK and its synergistic effects with doxorubicin-loaded nanodrug against HER2-positive breast cancer.

Xuesong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.